The first company-sponsored clinical trials of the gene editing system will treat genetic blood diseases

Company-sponsored CRISPR clinical trials set to start in 2018

By American Chemical Society —— Bio and Archives--January 16, 2018

Health and Medicine | Comments | Back To Full Article

This year could be a defining one for CRISPR, the gene editing technique, which has been hailed as an important breakthrough in laboratory research. That's because the first company-sponsored clinical studies will be conducted to see if it can help treat diseases in humans, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Comments

---

Support Canada Free Press

---

---

Recommended by Canada Free Press

---

---

---